King Pharmaceuticals acquires Ortho-McNeil HRT
Executive Summary
King Pharmaceuticals (life cycle marketing management of in-licensed branded drugs) will acquire from J&J's Ortho-McNeil Pharmaceutical the hormone replacement therapy Ortho-Prefest (estradiol/norgestimate tablets).
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
- Product Purchase
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice